Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	113,207	95,687	78,572	67,916	51,551	41,226
Market Cap Growth	17.61%	21.78%	15.69%	31.74%	25.04%	1.98%
Enterprise Value	105,390	87,545	73,531	64,921	50,660	38,726
PE Ratio	30.85	24.20	18.11	8.41	14.67	19.49
PS Ratio	8.64	7.30	6.46	4.23	6.07	6.29
PB Ratio	4.19	3.68	3.47	3.62	4.68	3.72
P/FCF Ratio	27.85	24.69	17.76	10.40	25.73	20.61
P/OCF Ratio	23.89	20.83	15.67	9.59	19.69	16.97
EV/Sales Ratio	8.05	6.67	6.04	4.04	5.96	5.91
EV/EBITDA Ratio	23.17	18.65	13.98	6.71	12.35	14.51
EV/EBIT Ratio	25.62	20.49	14.95	6.92	13.10	15.75
EV/FCF Ratio	25.93	22.59	16.62	9.94	25.29	19.36
Debt / Equity Ratio	0.10	0.10	0.12	0.14	0.24	0.06
Debt / EBITDA Ratio	0.59	0.58	0.51	0.28	0.66	0.27
Debt / FCF Ratio	0.67	0.70	0.61	0.41	1.35	0.36
Quick Ratio	4.40	4.82	4.16	2.98	2.86	2.86
Current Ratio	5.27	5.69	5.06	3.56	3.63	3.67
Asset Turnover	0.40	0.42	0.44	0.73	0.54	0.48
Interest Coverage	57.85	58.52	82.80	163.75	67.97	81.43
Return on Equity (ROE)	15.10%	16.10%	20.50%	51.20%	33.20%	20.70%
Return on Assets (ROA)	11.80%	12.60%	15.70%	36.60%	22.20%	15.50%
Return on Capital (ROIC)	12.38%	13.29%	16.68%	36.09%	24.03%	16.31%
Earnings Yield	3.41%	4.13%	5.52%	11.89%	6.82%	5.13%
FCF Yield	3.59%	4.05%	5.63%	9.61%	3.89%	4.85%
Buyback Yield / Dilution	-0.96%	-0.18%	-1.16%	2.52%	-0.44%	0.17%
Total Shareholder Return	-0.96%	-0.18%	-1.16%	2.52%	-0.44%	0.17%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).